Observational Study on the Clinical Profile of patients with Uncontrolled Severe Asthma Treated with Tezepelumab in Italy

Trial Identifier:	D5180R00031
Sponsor:	AstraZeneca
Start Date:	May 2025
Primary Completion Date:	May 2027
Study Completion Date:	May 2027
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.